Back to Agendas
HEALTH APPS: DEFINITION, REGULATION & USE
Session Chair(s)
Erik Vollebregt, JD, LLM
Partner
AXON Lawyers, Netherlands
More and more pharmaceutical companies make apps available for a variety of uses. This interactive session will provide an introduction about regulation of such apps, and will subsequently discuss these apps in eight broad functional categories, of which the attendees can choose three on demand that the panel will explore in-depth with respect to EU, US and quality system regulatory aspects and developments.
Speaker(s)
Introduction and Discussion of EU Requirements and Developments for Health Apps
Erik Vollebregt, JD, LLM
AXON Lawyers, Netherlands
Partner
Discussion of US Requirements and Developments for Health Apps
Bradley Merrill Thompson
Epstein, Becker and Green P.C., United States
General Counsel, Combination Products Coalition
Discussion of Quality System Requirements and Developments for Health Apps
Pierre Leurent
Voluntis, France
CEO
Have an account?